Skip to main content

Table 2 Baseline participant’s characteristics from the control and intervention groups

From: Foot-ankle functional outcomes of using the Diabetic Foot Guidance System (SOPeD) for people with diabetic neuropathy: a feasibility study for the single-blind randomized controlled FOotCAre (FOCA) trial I

  Control group (n = 8) Intervention group (n = 6)
Age (years) 50.5 (13.2) 52.5 (4.5)
Body mass (kg) 80.9 (25.1) 68.6 (10.6)
Height (m) 1.62 (0.08) 1.60 (0.11)
Body mass index (kg/m2) 30.4 (6.7) 26.4 (2.8)
Type of diabetes DM2 = 87.5% DM2 = 83.3%
Sex Female—6 Female—5
DPN severity (fuzzy score) 2.1 (2.1–6.0) a 2.1 (2.1–3.9) a
MNSI (score) 9.2 (2.3) 8.8 (2.6)
Tactile sensitivity (number of areas) right 0.0 (0.0–1.5) a 0.0 (0.0–1.0) a
Tactile sensitivity (number of areas) left 0.0 (0.0–2.5) a 0.0 (0.0–1.0) a
Tactile threshold right 2.0 (2.0–5.0) a 3.0 (1.0 – 4.0) a
Tactile threshold left 2.5 (2.0–4.5) a 3.0 (2.0–5.5) a
FHSQ foot pain (score) 56.3 (32.6) 38.6 (35.8)
FHSQ foot function (score) 72.6 (24.0) 63.5 (32.4)
FHSQ footwear (score) 38.5 (44.3) 27.7 (32.7)
FHSQ general foot health (score) 25.3 (22.4) 22.9 (38.2)
  1. Data are presented as mean (SD) or as n or %; a median (interquartile range)
  2. MNSI Michigan Neuropathy Screening Instrument, FHSQ Foot Health Status Questionnaire, DPN diabetic peripheral neuropathy, DM2 diabetes mellitus type 2